688513.SHG Chengdu Easton Biopharmaceuticals Co Ltd

Healthcare Biotechnology Shanghai Stock Exchange
42.37 CNY
Close of Nov 5, 2026
38.71 79.67
Market cap
CNY 7.48B
P/E
26.8x
P/B
2.40x
ROE
9.3%
Dividend yield
1.03%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 688513.SHG undervalued?

Graham number
Price42.37
Graham value25.04
Premium69.2%

688513.SHG trades 69.2% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Chengdu Easton Biopharmaceuticals Co Ltd fundamental analysis

No fundamental analysis for Chengdu Easton Biopharmaceuticals Co Ltd yet.

Chengdu Easton Biopharmaceuticals Co Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Chengdu Easton Biopharmaceuticals Co Ltd

Chengdu Easton Biopharmaceuticals Co., Ltd., together with its subsidiaries, engages in the research, development, manufacturing, and commercialization of pharmaceutical products in China and internationally. The company offers active pharmaceutical ingredients; finished dosage forms, including capsules, tablets, and injections; pharmaceutical intermediates; biological drugs; and generic drugs. Its products are used in oncology, cardiovascular, neurology and psychiatry, anes…

Full company profile